Learn about the global injectable drug delivery devices market through The Business Research Company, which provides information on injectable drug delivery devices market size, injectable drug delivery devices market drivers and restraints, injectable drug delivery devices market players, the COVID-19 impact on the injectable drug delivery devices market, and more.

The global injectable drug delivery devices market size is expected to grow from $34.49 billion in 2021 to $38.03 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The global injectable drug delivery market size is then expected to grow to $55.89 billion in 2026 at a CAGR of 10.1%.

The increasing preference for self-injection devices is driving the injectable drug delivery devices market.

Request A Sample For The Global Injectable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. These are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular, and others to treat medical conditions ranging from cancer to autoimmune disorders.

Global Injectable Drug Delivery Devices Market Segments Include:

By Type: Conventional Injectable, Prefilled Syringes, Auto-Injectors, Pen-Injectors

By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others

By End-User: Hospitals and Clinics, Home Healthcare Settings, Pharmaceutical and Biotechnological Companies, Research Laboratories, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the injectable drug delivery devices market in 2021.

The companies in injectable drug delivery devices are increasingly focusing on the manufacturing of auto-injectors. The auto-injectors are fully automated, highly customized, and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during injection. These devices can adjust the speed and depth of the automatic injection.

TBRC’s injectable drug delivery devices market report covers:

Major Market Players: Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Injectable Drug Delivery Devices Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market overviews, analyzes and forecasts market size, share, injectable drug delivery devices market players, injectable drug delivery devices market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s injectable drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2022

Autoinjectors Global Market Report 2022

Wearable Injectors Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: